These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 16368901)
1. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model. Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901 [TBL] [Abstract][Full Text] [Related]
2. Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury. Zhou Z; Wang K; Penn MS; Marso SP; Lauer MA; Forudi F; Zhou X; Qu W; Lu Y; Stern DM; Schmidt AM; Lincoff AM; Topol EJ Circulation; 2003 May; 107(17):2238-43. PubMed ID: 12719284 [TBL] [Abstract][Full Text] [Related]
3. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats. Wang X; Diao Y; Zhang H; Huo X; Zhang Q Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320 [TBL] [Abstract][Full Text] [Related]
6. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation. Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709 [TBL] [Abstract][Full Text] [Related]
7. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694 [TBL] [Abstract][Full Text] [Related]
8. PPARgamma-mediated advanced glycation end products regulation of neural stem cells. Wang SH; Sun ZL; Guo YJ; Yuan Y; Li L Mol Cell Endocrinol; 2009 Aug; 307(1-2):176-84. PubMed ID: 19524138 [TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure. Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075 [TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway. Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats. Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646 [TBL] [Abstract][Full Text] [Related]
13. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Takeda R; Suzuki E; Satonaka H; Oba S; Nishimatsu H; Omata M; Fujita T; Nagai R; Hirata Y Circulation; 2005 Mar; 111(11):1398-406. PubMed ID: 15781751 [TBL] [Abstract][Full Text] [Related]
14. Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation. Liu X; Luo D; Zheng M; Hao Y; Hou L; Zhang S Eur J Pharmacol; 2010 Mar; 629(1-3):153-8. PubMed ID: 20004657 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120 [TBL] [Abstract][Full Text] [Related]
17. Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S Biochem Biophys Res Commun; 2009 Jul; 385(2):269-72. PubMed ID: 19460355 [TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M; Wolf G Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750 [TBL] [Abstract][Full Text] [Related]
19. Grape seed proanthocyanidin extracts inhibit vascular cell adhesion molecule expression induced by advanced glycation end products through activation of peroxisome proliferators-activated receptor gamma. Ma L; Gao HQ; Li BY; Ma YB; You BA; Zhang FL J Cardiovasc Pharmacol; 2007 May; 49(5):293-8. PubMed ID: 17513948 [TBL] [Abstract][Full Text] [Related]
20. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]